Jul 27 2010
Stiefel, a GSK company, Brings Acne Innovation Directly to Consumers with MaxClarity™

Jul 16 2010
Stiefel, a GSK company, Receives FDA Approval of VELTIN™ (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%

Jul 22 2009
GlaxoSmithKline Completes Acquisition of Stiefel

Jun 2 2009
Stiefel Laboratories reaps first fruits of Barrier acquisition with completion of pivotal phase III clinical trial for 200 mg Hyphanox™ (itraconazole) tablet

Apr 20 2009
GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business

Mar 6 2009
Stiefel Laboratories Expands U.S. Consumer HealthCare Division: Launches Impruv® Dry Skin Product Line At Walgreens

Dec 4 2008
Stiefel Laboratories Announces The Expansison Of Its REVALÉSKIN® Skin Care Line With Three New Products

Oct 20 2008
Bob Cunard appointed President of Glades Pharmaceuticals